Home › Chronic Lymphocytic Leukemia › Indiana › Hammond
Chronic Lymphocytic Leukemia clinical trials in Hammond, IN
3 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Ingalls Memorial Hospital, Harvey · 8 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Ingalls Memorial Hospital, Harvey · 8 mi away
- Advocate South Suburban Hospital, Hazel Crest · 10 mi away
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RecruitingPhase 3
- Northwest Cancer Center - Dyer Clinic /ID# 268478, Dyer · 6 mi away
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH29 studies
- Durham, NC28 studies
- Washington, DC22 studies
- Seattle, WA22 studies
- Rochester, MN20 studies
- New York City, NY20 studies
- Houston, TX18 studies
- Baldwin Park, CA18 studies
- Cincinnati, OH15 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Ovarian Cancer5 studies
- High Blood Pressure4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colorectal Cancer4 studies
- Colon Cancer4 studies
- Blood Clots4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.